AKRO
Price
$51.84
Change
+$1.26 (+2.49%)
Updated
Feb 21 closing price
Capitalization
3.95B
18 days until earnings call
PHAT
Price
$5.67
Change
+$0.13 (+2.35%)
Updated
Feb 21 closing price
Capitalization
387.7M
9 days until earnings call
Ad is loading...

AKRO vs PHAT

Header iconAKRO vs PHAT Comparison
Open Charts AKRO vs PHATBanner chart's image
Akero Therapeutics
Price$51.84
Change+$1.26 (+2.49%)
Volume$852.11K
Capitalization3.95B
Phathom Pharmaceuticals
Price$5.67
Change+$0.13 (+2.35%)
Volume$723.07K
Capitalization387.7M
AKRO vs PHAT Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKRO vs. PHAT commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a Hold and PHAT is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (AKRO: $51.84 vs. PHAT: $5.67)
Brand notoriety: AKRO and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 58% vs. PHAT: 71%
Market capitalization -- AKRO: $3.95B vs. PHAT: $387.7M
AKRO [@Biotechnology] is valued at $3.95B. PHAT’s [@Biotechnology] market capitalization is $387.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, AKRO is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 4 TA indicator(s) are bullish while PHAT’s TA Score has 5 bullish TA indicator(s).

  • AKRO’s TA Score: 4 bullish, 6 bearish.
  • PHAT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PHAT is a better buy in the short-term than AKRO.

Price Growth

AKRO (@Biotechnology) experienced а +2.61% price change this week, while PHAT (@Biotechnology) price change was -1.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

AKRO is expected to report earnings on May 20, 2025.

PHAT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($3.95B) has a higher market cap than PHAT($388M). AKRO YTD gains are higher at: 86.341 vs. PHAT (-30.172). AKRO has higher annual earnings (EBITDA): -232.85M vs. PHAT (-272.21M). AKRO has more cash in the bank: 717M vs. PHAT (335M). AKRO has less debt than PHAT: AKRO (36.4M) vs PHAT (176M). PHAT has higher revenues than AKRO: PHAT (26.3M) vs AKRO (0).
AKROPHATAKRO / PHAT
Capitalization3.95B388M1,019%
EBITDA-232.85M-272.21M86%
Gain YTD86.341-30.172-286%
P/E RatioN/AN/A-
Revenue026.3M-
Total Cash717M335M214%
Total Debt36.4M176M21%
TECHNICAL ANALYSIS
Technical Analysis
AKROPHAT
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 18 days ago
83%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
Bearish Trend 12 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VTISX142.02-0.83
-0.58%
Vanguard Total Intl Stock Idx Instl Sel
TRWRX22.53-0.15
-0.66%
Transamerica International Equity R
GRGUX48.76-0.50
-1.02%
Goldman Sachs Equity Income R6
AMAFX10.77-0.21
-1.91%
American Century Small Cap Dividend I
RYVLX575.26-24.88
-4.15%
Rydex NASDAQ-100® 2x Strategy A